4.3 Article

Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis

Journal

ANTICANCER RESEARCH
Volume 39, Issue 5, Pages 2277-2287

Publisher

INT INST ANTICANCER RESEARCH
DOI: 10.21873/anticanres.13344

Keywords

Mammary carcinoma; mammary epithelium; micro-environment; orthotopic tumor model; triple-negative breast cancer

Categories

Funding

  1. National Institute of General Medical Sciences, NIH [P20GM103499]
  2. USC School of Medicine Research and Development Fund
  3. MOHESR-Iraqi scholarship
  4. SPARC
  5. Canadian Institutes of Health [142353]
  6. USC Science Undergraduate Research Fellowship
  7. USC Magellan Scholar Award
  8. USC School of Medicine Research Program for Medical Students
  9. [R01CA218578]
  10. [P01AT003961-8455]

Ask authors/readers for more resources

Background: Low success rates in oncology drug development are prompting re-evaluation of preclinical models, including orthotopic tumor engraftment. In breast cancer models, tumor cells are typically injected into mouse mammary fat pads (MFP). However, this approach bypasses the epithelial microenvironment, potentially altering tumor properties in ways that affect translational application. Materials and Methods: Tumors were generated by mammary intraductal (MIND) engraftment of 4T1 carcinoma cells. Growth, histopathology, and molecular features were quantified. Results: Despite growth similar to that of 4T1 MFP tumors, 4T1 MIND tumors exhibit distinct histopathology and increased metastasis. Furthermore, >6,000 transcripts were found to be uniquely up-regulated in 4T1 MIND tumor cells, including genes that drive several cancer hallmarks, in addition to two known therapeutic targets that were not up-regulated in 4T1 MFP tumor cells. Conclusion: Engraftment into the epithelial microenvironment generates tumors that more closely recapitulate the complexity of malignancy, suggesting that intraductal adaptation of orthotopic mammary models may be an important step towards improving outcomes in preclinical drug screening and development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available